Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2010 Jan;45(1):121-8; discussion 129.
doi: 10.1016/j.jpedsurg.2009.10.023.

Defining hepatoblastoma responsiveness to induction therapy as measured by tumor volume and serum alpha-fetoprotein kinetics

Harold N Lovvorn 3rd  1 , Dan Ayers, Zhiguo Zhao, Melissa Hilmes, Pinki Prasad, Myrick C Shinall Jr, Barry Berch, Wallace W Neblett 3rd, James A O'Neill Jr
Affiliations
Comparative Study

Defining hepatoblastoma responsiveness to induction therapy as measured by tumor volume and serum alpha-fetoprotein kinetics

Harold N Lovvorn 3rd et al. J Pediatr Surg. 2010 Jan.

Abstract

Purpose: Hepatoblastoma is commonly unresectable at presentation, necessitating induction chemotherapy before definitive resection. To refine the paradigm for timing of resection, we questioned whether a plateau in hepatoblastoma responsiveness to neoadjuvant therapy could be detected by calculating tumor volume (TV) and serum alpha-fetoprotein (sAFP) kinetics.

Methods: To calculate TV and sAFP as measures of treatment responsiveness over time, infants having initially unresectable epithelial-type hepatoblastomas were identified at a single institution (1996-2008). Effects of therapy type, therapy duration, and lobe of liver involvement on TV, sAFP, margin status, and toxicity were analyzed.

Results: Of 24 infants treated for epithelial-type hepatoblastoma during this interval, 5 were resected primarily, and 15 had complete digital films for kinetics analysis. Both TV and sAFP decreased dramatically over time (P < .0001). No statistically significant difference in mean TV or sAFP was detected after chemotherapy cycle 2. Left lobe tumors had greater presenting levels of and significantly slower decay in sAFP compared with right lobe tumors (P = .005), although no statistically significant differences in TV existed between liver lobes. Resection margins did not change with therapy duration.

Conclusions: Measuring TV and sAFP kinetics accurately reflects hepatoblastoma responsiveness to induction therapy. Treatment toxicities may be reduced by earlier resection and tailoring of chemotherapeutic regimens.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Graph shows number of patients having hepatoblastoma resection after each cycle of induction therapy.
Figure 2
Figure 2
Hepatoblastoma decay after each induction therapy cycle, as estimated by sAFP (A) and TV (B) kinetics. (C) Reduced monotonic regression curves show similar decay patterns between sAFP (red) and TV (blue) measurements.
Figure 3
Figure 3
Hepatoblastoma decay according to lobe of origin (left lobe, blue; right lobe, red). (A) Left lobe tumors present with higher sAFP levels and show slower decay. (B) TV changes according to lobe of origin. P-values represent mixed models ANOVA tests of lobe by time interactions.
Figure 4
Figure 4
Resection margins do not lengthen with increasing duration (A) or cycles (B) of induction therapy (ρ = Spearman correlation).
See this image and copyright information in PMC

References

    1. Litten JB, Tomlinson GE. Liver tumors in children. Oncologist. 2008 Jul;13(7):812–20. - PubMed
    1. Meyers RL. Tumors of the liver in children. Surg Oncol. 2007 Nov;16(3):195–203. - PubMed
    1. Herzog CE, Andrassy RJ, Eftekhari F. Childhood cancers: hepatoblastoma. Oncologist. 2000;5(6):445–53. - PubMed
    1. Ortega JA, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Finegold MJ, et al. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group. J Clin Oncol. 2000 Jul;18(14):2665–75. - PubMed
    1. Evans AE, Land VJ, Newton WA, Randolph JG, Sather HN, Tefft M. Combination chemotherapy (vincristine, adriamycin, cyclophosphamide, and 5-fluorouracil) in the treatment of children with malignant hepatoma. Cancer. 1982 Sep 1;50(5):821–6. - PubMed

Publication types

MeSH terms

Substances